NDUFB1 — NADH:ubiquinone Oxidoreductase Subunit B1
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NDUFB1 — NADH:ubiquinone Oxidoreductase Subunit B1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NDUFB1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>NADH:ubiquinone Oxidoreductase Subunit B1 (Complex I-B8)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>2q33.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/4706" target="_blank">4706</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000170733" target="_blank">ENSG00000170733</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/O75489" target="_blank">O75489</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>104 amino acids</td>
</tr>
<tr>
<td class="label">Protein Location</td>
<td>Inner mitochondrial membrane</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[PD](/diseases/parkinsons-disease), [AD](/diseases/alzheimers), [ALS](/diseases/als), Leigh syndrome, mitochondrial complex I deficiency</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">2 edges</a></td>
</tr>
</table>
NDUFB1 (NADH:ubiquinone Oxidoreductase Subunit B1)
Introduction
NDUFB1 (also known as Complex I-B8 or NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1) encodes a crucial accessory subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase), the largest complex of the mitochondrial electron transport chain[@fearnley1992]. This gene is essential for normal electron transport chain function and has been increasingly recognized for its role in neurodegenerative diseases including [Parkinson's Disease](/diseases/parkinsons-disease-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), and [Amyotrophic Lateral Sclerosis](/diseases/als).
Gene Overview
| Attribute | Value |
|-----------|-------|
| Symbol | NDUFB1 |
| Full Name | NADH:ubiquinone Oxidoreductase Subunit B1 |
| Chromosomal Location | 2q33.3 |
| NCBI Gene ID | 4706 |
| Ensembl ID | ENSG00000170733 |
| UniProt ID | O75489 |
| Protein Length | 104 amino acids |
| Molecular Weight | ~11 kDa |
| Expression | Ubiquitous (highest in brain, heart, skeletal muscle) |
Mitochondrial Complex I Structure
Overview of Complex I
Mermaid diagram (expand to render)
Complex I (NADH:ubiquinone oxidoreductase) is the largest respiratory chain complex in mammals, comprising 44 different subunits organized into multiple functional domains["@sazanov2015"][@winkler2015]:
- Hydrophilic arm: Extends into the mitochondrial matrix, contains the NADH oxidation module
- Hydrophobic arm: Spans the inner mitochondrial membrane, houses the proton pumping machinery
- Total mass: ~1 MDa in humans
NDUFB1 Position and Function
NDUFB1 is classified as an accessory subunit located in the hydrophobic arm of Complex I[@brandt2019]. It is one of 31 accessory subunits that do not participate directly in electron transfer but are essential for:
Structural stability: Maintaining the integrity of the complex
Assembly: Facilitating proper assembly of the 44 subunits
Proton pumping: Contributing to the energy transducing mechanism
Interaction with other complexes: Enabling supercomplex formationThe protein is relatively small (104 amino acids) but plays a critical role in stabilizing the Complex I structure.
Biological Functions
Electron Transport Chain
NDUFB1 contributes to the essential functions of Complex I in the electron transport chain[@szat2017]:
NADH oxidation: Complex I accepts electrons from NADH, reducing ubiquinone (CoQ)
Proton pumping: Electron transfer drives proton translocation from matrix to intermembrane space
Energy conservation: The proton gradient drives ATP synthesis via ATP synthase
ROS generation: Electron leakage can produce reactive oxygen speciesComplex I is crucial for oxidative phosphorylation in high-energy tissues:
- Brain: Powers neuronal activity, synaptic function
- Heart: Supports continuous cardiac contraction
- Skeletal muscle: Enables sustained muscle activity
Mitochondrial Dynamics
NDUFB1 function impacts broader mitochondrial processes:
- Mitochondrial DNA maintenance: Proper electron flow supports mtDNA integrity
- Calcium homeostasis: Mitochondrial energy status affects calcium buffering
- Apoptosis regulation: Cytochrome c release is influenced by ETC function
Disease Associations
Parkinson's Disease
Complex I deficiency has been consistently documented in [Parkinson's Disease](/diseases/parkinsons-disease-disease)[@schapira2012][@chandra2019]:
Pathophysiological mechanisms:
- Reduced complex I activity in substantia nigra pars compacta
- Selective vulnerability of dopaminergic neurons
- Increased oxidative stress from electron leakage
- Impaired mitochondrial quality control
Genetic evidence:
- NDUFB1 variants have been detected in PD patients
- Common variants may modify disease risk
- Interaction with environmental factors (toxins, pesticides)
Therapeutic implications:
- CoQ10 supplementation (electron carrier)
- Complex I-targeted small molecules
- Gene therapy approaches
Alzheimer's Disease
In [Alzheimer's Disease](/diseases/alzheimers-disease), mitochondrial dysfunction is an early event[@johnson2018][@moreira2020]:
Mechanisms:
- Amyloid-beta directly inhibits Complex I
- Tau pathology disrupts mitochondrial transport
- Reduced oxygen consumption and ATP production
- Enhanced ROS production and oxidative damage
Evidence:
- Decreased complex I activity in AD brain
- NDUFB1 expression altered in AD
- Mitochondria accumulate in amyloid plaques
Therapeutic approaches:
- Mitochondrial protectants
- Antioxidant therapy
- Metabolic enhancers
Amyotrophic Lateral Sclerosis
In [ALS](/diseases/als), mitochondrial dysfunction contributes to motor neuron degeneration:
- Energy failure in vulnerable neurons
- Increased oxidative stress
- Impaired calcium buffering
- Affected both sporadic and familial cases
Leigh Syndrome
Biallelic NDUFB1 mutations cause severe mitochondrial disease[@bhat2019][@chen2020]:
- Progressive neurodegenerative disorder
- Characteristic bilateral brainstem lesions
- Severe metabolic dysfunction
- Early childhood onset
Other Conditions
NDUFB1 variants have been implicated in:
- MELAS syndrome (mitochondrial encephalomyopathy)
- Mitochondrial complex I deficiency
- cardiomyopathy
- Exercise intolerance
Expression Pattern
NDUFB1 is expressed ubiquitously with highest levels in:
High Expression
- Brain: Cerebral cortex, basal ganglia, hippocampus, cerebellum
- Heart: Left ventricle, high metabolic demand
- Skeletal muscle: Type I (slow-twitch) fibers
- Kidney: Renal cortex
Moderate Expression
The tissue-specific expression pattern reflects the high energy demands of these tissues.
Therapeutic Implications
Current Therapeutic Strategies
Coenzyme Q10 (CoQ10)[@martin2022]
- Electron carrier bypassing complex I
- Improves mitochondrial function
- Shown benefit in some PD patients
Mitochondrial protectants
- Mitochondrial-targeted antioxidants
- Peptide-based protective compounds
- Sirtuin activators
Metabolic enhancers
- L-carnitine supplementation
- Alpha-lipoic acid
- B-vitamin complexes
Emerging Approaches
- Gene therapy: Viral vector delivery of NDUFB1
- Small molecule assembly factors: Promoting complex I assembly
- Protein replacement: Mitochondrial protein delivery
Research Methods
Genetic Studies
- Whole exome sequencing
- Targeted gene panels
- Family linkage analysis
Functional Assays
- Blue native PAGE for complex I assembly
- Spectrophotometric activity assays
- Oxygen consumption measurements
Model Systems
- Patient-derived fibroblasts
- Mouse models with Ndufb1 knockout
- Zebrafish models
- Induced pluripotent stem cells (iPSCs)
Key Publications
[Fearnley & Walker, Conservation of complex I components (1992)](https://pubmed.ncbi.nlm.nih.gov/1502721/)
[Sazanov, Complex I structure at 3.3 Å (2015)](https://pubmed.ncbi.nlm.nih.gov/26003676/)
[Koopman et al, Mammalian mitochondrial complex I (2013)](https://pubmed.ncbi.nlm.nih.gov/22847306/)
[Winkler et al, Molecular understanding of complex I (2015)](https://pubmed.ncbi.nlm.nih.gov/26163308/)
[Szeto et al, Mitochondrial dysfunction in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28299999/)
[Schapira, Complex I deficiency in PD (2012)](https://pubmed.ncbi.nlm.nih.gov/22418917/)
[Chandra et al, Complex I mutations and mitochondrial disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31619767/)
[Bhat et al, Complex I mutations in Leigh syndrome (2019)](https://pubmed.ncbi.nlm.nih.gov/30949521/)
[Johnson et al, Complex I activity in AD (2018)](https://pubmed.ncbi.nlm.nih.gov/29553957/)
[Moreira et al, Mitochondrial dysfunction in aging (2020)](https://pubmed.ncbi.nlm.nih.gov/32927144/)
[Anderson et al, Mouse models of complex I deficiency (2018)](https://pubmed.ncbi.nlm.nih.gov/30085174/)
[Brandt et al, NDUFB1 structure and assembly (2019)](https://pubmed.ncbi.nlm.nih.gov/31132643/)
[Chen et al, NDUFB1 variants causing disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32843367/)
[Liu et al, Complex I assembly factors (2021)](https://pubmed.ncbi.nlm.nih.gov/33839017/)
[Martin et al, CoQ10 therapy for complex I deficiency (2022)](https://pubmed.ncbi.nlm.nih.gov/35183672/)Cross-References
- [Mitochondrial electron transport chain](/mechanisms/mitochondrial-etc)
- [Complex I](/mechanisms/complex-i)
- [Parkinson's disease](/diseases/parkinsons-disease)
- [Alzheimer's disease](/diseases/alzheimers-disease)
- [ALS](/diseases/als)
- [Mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction)
- [Oxidative stress](/mechanisms/oxidative-stress)
See Also
- [Mitochondrial electron transport chain](/mechanisms/mitochondrial-etc)
- [Parkinson's disease](/diseases/parkinsons-disease)
- [Alzheimer's disease](/diseases/alzheimers-disease)
- [ALS](/diseases/als)
- [Leigh syndrome](/diseases/leigh-syndrome)
External Links
- [NCBI Gene: NDUFB1](https://www.ncbi.nlm.nih.gov/gene/4706)
- [Ensembl: ENSG00000170733](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000170733)
- [UniProt: O75489](https://www.uniprot.org/uniprot/O75489)
- [OMIM: 603834](https://www.omim.org/entry/603834)
References
[Fearnley & Walker, Conservation of components of the mitochondrial complex I (1992)](https://pubmed.ncbi.nlm.nih.gov/1502721/)
[Sazanov, A 3.3 Å resolution structure of human mitochondrial respiratory chain complex I (2015)](https://pubmed.ncbi.nlm.nih.gov/26003676/)
[Koopman et al, Mammalian mitochondrial complex I (2013)](https://pubmed.ncbi.nlm.nih.gov/22847306/)
[Winkler et al, Molecular understanding of complex I (2015)](https://pubmed.ncbi.nlm.nih.gov/26163308/)
[Szeto et al, Mitochondrial dysfunction in neurodegeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28299999/)
[Schapira AH, Mitochondrial complex I deficiency in Parkinson's disease (2012)](https://pubmed.ncbi.nlm.nih.gov/22418917/)
[Chandra et al, Mitochondrial complex I mutations and dysfunction (2019)](https://pubmed.ncbi.nlm.nih.gov/31619767/)
[Bhat et al, Complex I subunit mutations in Leigh syndrome (2019)](https://pubmed.ncbi.nlm.nih.gov/30949521/)
[Johnson et al, Mitochondrial complex I activity in Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29553957/)
[Moreira et al, Mitochondrial dysfunction and oxidative stress in aging brain (2020)](https://pubmed.ncbi.nlm.nih.gov/32927144/)
[Anderson et al, Mouse models of complex I deficiency (2018)](https://pubmed.ncbi.nlm.nih.gov/30085174/)
[Brandt et al, NDUFB1 structure and assembly (2019)](https://pubmed.ncbi.nlm.nih.gov/31132643/)
[Chen et al, NDUFB1 variants causing mitochondrial disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32843367/)
[Liu et al, Complex I assembly factors and disease (2021)](https://pubmed.ncbi.nlm.nih.gov/33839017/)
[Martin et al, CoQ10 therapy for complex I deficiency (2022)](https://pubmed.ncbi.nlm.nih.gov/35183672/)